Cardiac tamponade epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
*#Metastatic cancer:(odds ratio:1.90) | *#Metastatic cancer:(odds ratio:1.90) | ||
*#Acute kidney injury(odds ratio:1.91) | *#Acute kidney injury(odds ratio:1.91) | ||
*#Idiopathic pericarditis (odds ratio: 0.21, least cause of mortality) | *#Idiopathic pericarditis (odds ratio: 0.21, least cause of mortality) | ||
===Age=== | ===Age=== | ||
| Line 33: | Line 33: | ||
* It needs around 12 days of hospitalization and a mean cost of $160,397. | * It needs around 12 days of hospitalization and a mean cost of $160,397. | ||
===Developed Countries=== | |||
* The leading cause of developing tamponade in developed countries is cancer.<ref name="pmid16051963" /> | |||
==References== | ==References== | ||
Revision as of 03:52, 15 January 2020
|
Cardiac tamponade Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiac tamponade epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cardiac tamponade epidemiology and demographics |
|
Risk calculators and risk factors for Cardiac tamponade epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
The cardiac tamponade is most often attributed to the rupture of an acute myocardial infarction or an intrapericardial rupture of a dissecting ascending aortic aneurysm. In developed countries malignancy is the leading cause of cardiac tamponade secondary to pericardial effusion.
Epidemiology and Demographics
Incidence
- The incidence of cardiac tamponade based on a giant sample size of about 216 million emergency admissions was about 115,638(0.05%)[1]
Case-fatality rate/Mortality rate
- Cardiac temponade mortality rate is significantly different due to its underlying cause.[2][1]
- Overall, hospitalized mortality rate is around 14.3% and sub groups with higher mortality are :
- Sepsis (odds ratio:3.17)
- Chest trauma (odds ratio:2.15)
- Metastatic cancer:(odds ratio:1.90)
- Acute kidney injury(odds ratio:1.91)
- Idiopathic pericarditis (odds ratio: 0.21, least cause of mortality)
Age
Race
- There is no racial predilection to cardiac tamponade.
Gender
- Cardiac tamponade affects men and women equally.
- There is no study suggesting a meaningful sex difference among diagnosed patients.
Approximate Health Care cost In US
- It needs around 12 days of hospitalization and a mean cost of $160,397.
Developed Countries
- The leading cause of developing tamponade in developed countries is cancer.[3]
References
- ↑ 1.0 1.1 1.2 "CARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology".
- ↑ Porte HL, Janecki-Delebecq TJ, Finzi L, Métois DG, Millaire A, Wurtz AJ (1999). "Pericardoscopy for primary management of pericardial effusion in cancer patients". Eur J Cardiothorac Surg. 16 (3): 287–91. PMID 10554845.
- ↑ 3.0 3.1 Gornik HL, Gerhard-Herman M, Beckman JA (2005). "Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion". J Clin Oncol. 23 (22): 5211–6. doi:10.1200/JCO.2005.00.745. PMID 16051963.